ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 84 filers reported holding ANTARES PHARMA INC in Q4 2013. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $1,166,000 | -7.1% | 530,246 | -16.0% | 0.00% | 0.0% |
| Q4 2017 | $1,255,000 | -5.4% | 631,049 | +54.3% | 0.00% | 0.0% |
| Q3 2017 | $1,326,000 | +2.1% | 408,944 | +1.2% | 0.00% | 0.0% |
| Q2 2017 | $1,299,000 | +6736.8% | 403,975 | +2483.8% | 0.00% | – |
| Q4 2015 | $19,000 | +5.6% | 15,635 | +46.1% | 0.00% | – |
| Q3 2015 | $18,000 | -45.5% | 10,704 | -32.9% | 0.00% | – |
| Q2 2015 | $33,000 | -2.9% | 15,951 | +25.7% | 0.00% | – |
| Q1 2015 | $34,000 | +9.7% | 12,685 | +6.6% | 0.00% | – |
| Q4 2014 | $31,000 | +10.7% | 11,902 | +13.4% | 0.00% | – |
| Q2 2014 | $28,000 | -45.1% | 10,492 | -8.6% | 0.00% | – |
| Q4 2013 | $51,000 | +15.9% | 11,481 | +6.4% | 0.00% | – |
| Q3 2013 | $44,000 | +4.8% | 10,793 | +7.1% | 0.00% | – |
| Q2 2013 | $42,000 | – | 10,077 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 3,130,192 | $12,834,000 | 5.32% |
| Velan Capital Investment Management LP | 1,346,971 | $5,523,000 | 5.12% |
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 2,799,953 | $11,480,000 | 4.03% |
| Sargent Investment Group, LLC | 3,663,275 | $15,019,000 | 3.78% |
| PERKINS CAPITAL MANAGEMENT INC | 481,483 | $1,974,000 | 1.62% |
| Rubric Capital Management LP | 10,900,000 | $44,690,000 | 1.62% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,720,000 | $7,052,000 | 1.39% |
| Long Focus Capital Management, LLC | 540,000 | $2,214,000 | 0.28% |
| OBERWEIS ASSET MANAGEMENT INC/ | 344,200 | $1,411,000 | 0.28% |
| FIRETHORN WEALTH PARTNERS, LLC | 84,069 | $345,000 | 0.26% |